XML 22 R6.htm IDEA: XBRL DOCUMENT v3.3.1.900
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows from operating activities:      
Net income $ 20,853 $ 15,838 $ 19,296
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 13,780 11,945 11,748
Gain on sale of businesses and purchase of other assets (49) (2,150) (6,091)
Impairment of goodwill 0 1,180 100
Loss on early extinguishment of debt and other costs 0 1,042 0
Amortization of deferred financing costs 921 908 362
Accretion of discount on convertible subordinated notes 3,454 2,452 0
Provision for losses on accounts receivable 1,679 2,877 2,005
Stock-based compensation expense 4,444 4,622 3,583
Deferred income tax expense 3,035 5,295 12,572
Loss on redemption of convertible junior subordinated debentures 0 2,932 0
Other 0 0 85
Changes in operating assets and liabilities that provided (required) cash:      
Accounts and preneed receivables (2,310) (4,146) (3,329)
Inventories and other current assets 2,582 (2,590) (337)
Deferred charges and other 150 (165) (35)
Preneed funeral and cemetery trust investments 25,543 (203) (1,415)
Accounts payable 1,445 (562) 1,142
Accrued and other liabilities 509 (1,529) (3,294)
Deferred preneed funeral and cemetery revenue 329 303 1,187
Deferred preneed funeral and cemetery receipts held in trust (26,461) (1,484) 2,266
Net cash provided by operating activities 49,904 36,565 39,845
Cash flows from investing activities:      
Acquisitions and land for new construction (9,725) (57,874) (19,701)
Purchase of land and buildings previously leased (6,080) (7,600) 0
Net proceeds from sale of businesses and other assets 65 2,192 10,184
Capital expenditures (29,744) (16,075) (10,695)
Net cash used in investing activities (45,484) (79,357) (20,212)
Cash flows from financing activities:      
Net (payments) borrowings on the revolving credit facility 52,100 3,600 (7,800)
Net borrowings (payments) on the term loan (9,375) 3,313 0
Proceeds from the issuance of convertible subordinated notes 0 143,750 0
Payment of debt issuance costs related to the convertible subordinated notes 0 (4,650) 0
Payments on long-term debt and obligations under capital leases (1,014) (840) (11,219)
Redemption of convertible junior subordinated debentures 0 (89,748) 0
Payments for performance-based stock awards 0 (16,150) 0
Proceeds from the exercise of stock options and employee stock purchase plan contributions 758 1,228 894
Dividends on common stock (1,819) (1,840) (1,817)
Dividends on redeemable preferred stock 0 0 (4)
Payment of loan origination costs (13) (825) (621)
Excess tax benefit of equity compensation 64 3,990 613
Purchase of treasury stock (44,999) 0 0
Net cash provided by (used in) financing activities (4,298) 41,828 (19,954)
Net (decrease) increase in cash and cash equivalents 122 (964) (321)
Cash and cash equivalents at beginning of year 413 1,377 1,698
Cash and cash equivalents at end of year $ 535 $ 413 $ 1,377